
Anti-obesogenic and hypolipidemic effects of a glucagon-like peptide-1 receptor agonist derived from the saliva of the Gila monster
Keywords: اختلالات چربی خون یا دیسپیدمی; Obesity; Dyslipidemia; Incretin; Drug repurposing; Lizard toxin; AUC; area under the time-course curve of glycemia; DIO; obesity induced by high-calorie diet; DIO-E; obesity induced by high-calorie diet treated with exenatide; T2D; type 2 diabetes mellitu